AI-Clinical Summit 2027
The Oncology & Targeted Therapies track focuses on the latest advancements in cancer research, diagnosis, and personalized treatment strategies. This track highlights breakthroughs in molecular oncology, tumor biology, immunotherapy, and precision-based targeted treatments designed to attack specific genetic and cellular abnormalities. Sessions will explore the development of small molecule inhibitors, monoclonal antibodies, antibody–drug conjugates, and CAR-T cell therapies, emphasizing improved efficacy and reduced systemic toxicity compared to conventional chemotherapy. Attention will also be given to biomarker-driven treatment selection and resistance mechanisms that influence therapeutic outcomes. In addition, the track addresses innovative clinical trial designs, combination therapies, and translational research approaches that accelerate the development of next-generation cancer treatments.
- Oncology Research & AI-Enabled Therapeutics
- Biomarker-Driven Trial Innovation
Related Sessions
Tags
- Oncology & Targeted Therapies Conferences
- Oncology & Targeted Therapies Conferences
- Oncology & Targeted Therapies Events
- Oncology & Targeted Therapies Events
- Oncology & Targeted Therapies Meetings
- Oncology & Targeted Therapies Meetings
- Hybrid Event
- Hybrid Events
- Oncology & Targeted Therapies
- Oncology & Targeted Therapies Workshop
- Oncology & Targeted Therapies Workshops
- Oncology & Targeted Therapies & Clinical Oncology & Targeted Therapies
- Oncology & Targeted Therapies & Clinical Oncology & Targeted Therapies
- Oncology & Targeted Therapies Symposium
- Oncology & Targeted Therapies Symposium
- Oncology & Targeted Therapies Conference
- Oncology & Targeted Therapies Conference
- Oncology & Targeted Therapies Seminars
- Oncology & Targeted Therapies Seminars